Mivacurium Chloride (CAS 106861-44-3)

Mivacurium is a chemical compound that functions as a non-depolarizing neuromuscular blocking agent. It interacts with nicotinic acetylcholine receptors at the neuromuscular junction, specifically targeting the alpha subunit of the receptor. By binding to these receptors, mivacurium competitively inhibits the action of acetylcholine, the endogenous neurotransmitter responsible for muscle contraction. This blockade of nicotinic receptors prevents the depolarization of the muscle cell membrane, ultimately leading to muscle relaxation. Mivacurium′s mechanism of action involves interfering with the transmission of nerve impulses to the muscle, effectively inhibiting the initiation and propagation of action potentials. As a result, the chemical influences cellular processes by disrupting the normal communication between motor neurons and muscle fibers, leading to temporary paralysis. This functional role of mivacurium in interfering with neuromuscular transmission makes it useful in various medical procedures requiring muscle relaxation, such as surgical interventions and mechanical ventilation.